1800 Howell Mill Road NW

Suite 475

Atlanta, GA 30318

 

p - 678-961-2100

f  - 678-961-2107

 

Open Monday through Thursday 8:30am-4:30pm

Current Research Studies At Our Practice

Because of our innovative nature, we always have at least one study or clinical trial going on at the practice. These studies and trials offer our patients access to treatments and medicines that are not yet in market.  These studies cost nothing to join and often times include money to be put towards food and transportation expenses. To see if you might be right to join a study, review the options available below. If a study interests you and is open, please call our office to speak to a study coordinator and enroll in the study.

Versartis 13VR3 Trial

STATUS:

Synopsis of Study:

Currently, growth hormone is given as a once daily injection.  The purpose of this study is to determine how well a new monthly growth hormone injection helps children grow.  Although this study is not currently enrolling new patients, we hope to have another opportunity for new patients starting late fall or early spring.  This study is currently open to patients with growth hormone deficiency.

Open

Novo NN2211-3659: ELLIPSE trial

STATUS:

Synopsis of Study:

This study was enrolling pediatric patients with type 2 diabetes.  Although the study medication, liraglutide, is currently approved for use in adults, it has not yet been approved for use in children.   This study will determine how liraglutide can help children who are not responding to their current treatment regimen (i.e. are still having high blood sugars or a high hemoglobin A1c despite taking metformin or insulin injections).

Closed

Versartis 14VR4 Trial

STATUS:

Synopsis of Study:

Currently, growth hormone is only available as a once daily injection.  This is a phase III trial that will compare the effectiveness of daily growth hormone injections versus semi-monthly injections of VRS-317, a new, long-acting growth hormone.  This study will only be open to patients with growth hormone deficiency who have never been on growth hormone therapy before.

Closed